Novel Liposome Nanoparticles for Tumor Magnetic Resonance Imaging
    1.
    发明申请
    Novel Liposome Nanoparticles for Tumor Magnetic Resonance Imaging 审中-公开
    用于肿瘤磁共振成像的新型脂质体纳米颗粒

    公开(公告)号:US20130129636A1

    公开(公告)日:2013-05-23

    申请号:US13511126

    申请日:2010-11-19

    IPC分类号: A61K49/18

    摘要: The present invention provides novel liposomes comprising Gd.DOTA.DSA (gadolinium(III)2-{4,7-bis-carboxymethyl-10-[(N,N-distearylamidomethyl-N′-amido-methyl]-1,4,7,10-tetra-azacyclododec-1-yl}-acetic acid), characterised in that said liposome further comprises a neutral, fully saturated phospholipid component (e.g. DSPC (1,2-distearoyl-sn-glycero-3-phosphocholine]), which are of particular use in the preparation of magnetic resonance contrast agents for enhancing a magnetic resonance image of tumours in a mammal.

    摘要翻译: 本发明提供了包含Gd.DOTA.DSA(钆(III)2- {4,7-双 - 羧甲基-10 - [(N,N-二硬脂酰氨基甲基-N'-酰氨基 - 甲基] 7,10-四氮杂环十二烷-1-基} - 乙酸),其特征在于所述脂质体还包含中性完全饱和的磷脂组分(例如DSPC(1,2-二硬脂酰-sn-甘油-3-磷酸胆碱)) ,其特别用于制备用于增强哺乳动物肿瘤的磁共振图像的磁共振造影剂。